Literature DB >> 24151171

Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature.

Daniel Taupin, Rikki Racela, Daniel Friedman.   

Abstract

We present a patient with peritoneal carcinosarcoma who was treated with the alkylating agent ifosfamide and experienced a rapid decline in mental status. Electroencephalogram (EEG) displayed generalized periodic epileptiform discharges, which raised suspicion for nonconvulsive status epilepticus (NCSE). Following administration of midazolam, the patient's clinical condition and EEG improved. We review the 8 documented cases of ifosfamide-induced NCSE, and demonstrate the similarity in clinical features when compared with ifosfamide neurotoxicity that is not classified as NCSE. EEG findings suggesting an ictal pattern are subtle and heterogeneous, but they are essential for a diagnosis. Since it is unlikely that EEGs are uniformly obtained in instances of ifosfamide neurotoxicity, many cases of NCSE may go unrecognized.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24151171     DOI: 10.1177/1550059413500777

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  2 in total

Review 1.  Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity.

Authors:  Pooja Gupta; Tavneet Kaur Makkar; Lavisha Goel; Monika Pahuja
Journal:  Immunol Res       Date:  2022-07-20       Impact factor: 4.505

Review 2.  Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage.

Authors:  Iside Alessi; Anna Maria Caroleo; Luca de Palma; Angela Mastronuzzi; Stefano Pro; Giovanna Stefania Colafati; Alessandra Boni; Nicoletta Della Vecchia; Margherita Velardi; Melania Evangelisti; Alessia Carboni; Andrea Carai; Luciana Vinti; Massimiliano Valeriani; Antonino Reale; Pasquale Parisi; Umberto Raucci
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.